Literature DB >> 19225012

Klotho in chronic kidney disease--what's new?

Makoto Kuro-o.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19225012     DOI： 10.1093/ndt/gfp069

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  12 in total

Review 1.  [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism].

Authors:  J Bacchetta; P Cochat; I B Salusky
Journal:  Arch Pediatr       Date:  2011-04-16       Impact factor: 1.180

Review 2.  Role of Klotho in aging, phosphate metabolism, and CKD.

Authors:  George B John; Chung-Yi Cheng; Makoto Kuro-o
Journal:  Am J Kidney Dis       Date:  2011-04-15       Impact factor: 8.860

3.  Fibroblast growth factor 23 and Inflammation in CKD.

Authors:  Jair Munoz Mendoza; Tamara Isakova; Ana C Ricardo; Huiliang Xie; Sankar D Navaneethan; Amanda H Anderson; Lydia A Bazzano; Dawei Xie; Matthias Kretzler; Lisa Nessel; L Lee Hamm; Lavinia Negrea; Mary B Leonard; Dominic Raj; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

4.  Association of polymorphisms in the klotho gene with severity of non-diabetic ESRD in African Americans.

Authors:  Meredith A Bostrom; Pamela J Hicks; Lingyi Lu; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2010-04-22       Impact factor: 5.992

5.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Authors:  Tamara Isakova; Patricia Wahl; Gabriela S Vargas; Orlando M Gutiérrez; Julia Scialla; Huiliang Xie; Dina Appleby; Lisa Nessel; Keith Bellovich; Jing Chen; Lee Hamm; Crystal Gadegbeku; Edward Horwitz; Raymond R Townsend; Cheryl A M Anderson; James P Lash; Chi-Yuan Hsu; Mary B Leonard; Myles Wolf
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

6.  Phosphorus metabolism in chronic kidney disease.

Authors:  C Fourtounas
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

7.  Cardiovascular remodeling as a result of fibroblast growth factor-23 (FGF-23)/Klotho imbalance in patients with CKD.

Authors:  Ludmila Yu Milovanova; Marina V Taranova; Svetlana Yu Milovanova; Lidia V Kozlovskaya Lysenko; Anastasia I Pasechnik; Vasiliy V Kozlov; Vladimir D Beketov; Alexey V Volkov; Mikhail Ratanov
Journal:  Int Urol Nephrol       Date:  2021-10-30       Impact factor: 2.370

Review 8.  Overview of the FGF23-Klotho axis.

Authors:  Makoto Kuro-o
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

Review 9.  Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.

Authors:  Fang-Ke Hu; Fang Yuan; Cheng-Ying Jiang; Da-Wei Lv; Bei-Bei Mao; Qiang Zhang; Zeng-Qiang Yuan; Yan Wang
Journal:  Chin J Cancer       Date:  2011-11

Review 10.  Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.

Authors:  Joao F de Brito Galvao; Larry A Nagode; Patricia A Schenck; Dennis J Chew
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2013 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.